Caplin Point Laboratories Limited Price (CAPLIPOINT.NS)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

76,309,309

(0.258)%

Community Sentiment 0 votes
↑ 0% ↓ 0%

Description

Caplin Point Laboratories Limited develops, produces, markets, and exports generic pharmaceutical formulations and branded products in India. The company provides liquid and lyophilized injections, ophthalmic products, tablets, liquid orals, capsules, softgel capsules, suppositories and ovules, powder for injection, dry syrups, topicals, inhalers, IV infusions, lyophilized products, branded products, dermo cosmetics, and other products. It also operates QueTenX, an e-commerce website. The company was incorporated in 1990 and is headquartered in Chennai,... Read More

Sector: Healthcare

  • Previous Close Fetching Data...
  • Range $1225-2641
  • Market Cap 141.72B
  • Enterprise Value No Data
  • Avg Volume Fetching Data...
  • P/E Ratio Fetching Data...
  • Dividend Yield Fetching Data...

Industry: Drug Manufacturers - Specialty & Generic

  • ceo: Dr. Sridhar Ganesan
  • IPO Date: June, 23, 2014
  • Country: IN
  • Currency: INR
  • Headquaters: No Data
  • Employees: 3406

- Revenue from each product or segment:

Product or Segment Value: % - Total Last 3Y:
news-img

- Revenue by Region

Product or Segment Value: % - Total Last 3Y:
news-img
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation